Netherlands's Coronary Stents Market is expected to witness growth from $29 Mn in 2022 to $44 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The elderly in the Netherlands are becoming more prevalent, which increases their chance of developing coronary artery disease. The demand for coronary stents and other cardiovascular devices is anticipated to rise as the population continues to age. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Hy2Care B.V., InnoSer, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
Netherlands's Coronary Stents Market is expected to witness growth from $29 Mn in 2022 to $44 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. National healthcare spending in the Netherlands increased by an average of over 5% annually from 2022 to a total of more than $117.89 billion. For a population of more than 17 million people, this amounted to approximately $7840.54 in Dutch healthcare expenditures per person.
In the Netherlands, coronary artery disease affects about 1 in 15 men and 1 in 25 women, making it one of the most prevalent cardiovascular disorders. The prevalence of CAD rises with aging, with rates over 75 years old showing the greatest rates. Coronary stents are thin wire mesh tubes that are utilized to support open cardiac arteries that have been obstructed or constricted as a result of plaque development. Coronary stents increase blood flow to the heart muscle by opening up restricted or obstructed arteries, which can ease symptoms including shortness of breath and chest pain. By preventing plaque from rupturing and forming a blood clot, coronary stents can help lower the risk of having a heart attack. Placing a coronary stent is a minimally invasive operation that is frequently done without an overnight stay. Shorter hospital stays, quicker recoveries, and a lower chance of problems can all result from this. After stent placement, restenosis, or re-narrowing of the artery, might happen. Drug-eluting stents, which release medication to aid in preventing the development of new blockages, reduce the risk of restenosis.
Market Growth Drivers
The elderly in the Netherlands are becoming more prevalent, which increases their chance of developing coronary artery disease. The demand for coronary stents and other cardiovascular devices is anticipated to rise as the population continues to age. In the Netherlands, there is a rising awareness of the dangers of cardiovascular disease, which is encouraging higher screening and earlier CAD diagnosis. Demand for coronary stents and other cardiovascular devices should increase as a result of this trend. New and improved coronary stents have been created as a result of technological advancements, and they provide superior performance, increased safety, and a lower risk of problems. The Netherlands' demand for coronary stents is anticipated to increase as a result of these advancements.
Market Restraints
In the Netherlands, manufacturers must adhere to a variety of laws and norms, which can prevent them from entering a market or prevent them from releasing new products. Patients with coronary artery disease frequently receive coronary stents as a treatment option; however, other options include medicinal therapy and coronary artery bypass grafting. The demand for coronary stents may be constrained by the availability of these alternative therapies. Since coronary stent procedures can be expensive, demand may be constrained, especially in situations where patients or healthcare providers are unwilling to cover the associated costs.
Key Players
The Dutch Healthcare Authority (NZa), the Ministry of Health, Welfare and Sport (VWS), and the Healthcare Inspectorate (IGJ) are a few of the organisations that keep an eye on the regulatory environment and ethical standards in the market for coronary stents in the Netherlands. All medical devices, including coronary stents, are subject to medical device rules including the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), which work to ensure the safety and effectiveness of medical devices marketed in the EU. The Healthcare Inspectorate (IGJ), which oversees and enforces rules concerning the safety and calibre of medical devices, is concerned with coronary stents. The IGJ inspects enterprises that produce medical devices to ensure that regulations are being obeyed, and it has the power to start enforcement actions against those businesses.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cNetherlandsity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.
By Mode of Delivery (Revenue, USD Billion):
The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.
By Materials (Revenue, USD Billion):
The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.
By End User (Revenue, USD Billion):
The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.